Deadline: Pfizer Migraine Research
This competitive call for collaborator(s) (CFC(s)) seeks to identify investigators with innovative research proposals who are interested in partnering with Pfizer and potentially other likeminded investigators on co-developing research studies in migraine. Proposals selected from this CFC(s) will work in collaboration with the Pfizer medical team to co-develop a research project and final study protocol. In all studies, the investigator will be the regulatory sponsor of the study.
This CFC will be a two-step process. The first step will be for investigators to submit a LOI providing a high-level synopsis of the proposed project. In the second step, the LOI will be selected for further development into a research collaboration with Pfizer.
Contact Details
Internal: ors.int@dal.ca
External: Sue Lee, (sue.lee@pfizer.com), with the subject line 鈥淕lobal Call for Collaborators 鈥� Pfizer Migraine Research 鈥� October 2024鈥�.
Deadlines
Internal: LOI: October 30, 2024
External: LOI: November 13, 2024, 11:59 EST
Unless otherwise specified, the standard internal deadline is 10 business days ahead of the funder deadline. The grants facilitator for your faculty or this opportunity can be found on the staff contact page. For additional resources, click here for guidance on internal deadlines and submission processes.
Time
Additional Dates/Times